Form 4: Metropolitan Bank Director Sells Shares, Receives RSUs
Insider Trading Report
Metropolitan Bank Holding Corp. director Robert C. Patent reported selling 14,445 shares and acquiring 2,500 restricted stock units in late January 2026.
Summary
- Director Robert C. Patent of Metropolitan Bank Holding Corp. reported multiple transactions in the company's common stock.
- Between January 22 and January 23, 2026, Patent sold a total of 14,445 shares of common stock.
- The sales occurred at weighted average prices ranging from $90.044 to $96.1553 per share.
- On January 23, 2026, Patent also acquired 2,500 restricted stock units (RSUs) at a price of $0, which are scheduled to vest 100% on January 23, 2027.
- Following these transactions, Patent directly beneficially owns 86,740 shares, which includes RSUs vesting on January 27, 2026, and January 23, 2027.
- Additionally, Patent indirectly beneficially owns 14,445 shares through a Profit Sharing Plan.
- All reported transactions were made pursuant to a Rule 10b5-1 pre-planned trading arrangement.
Sentiment
Score: 4
Explanation: The director's net selling of shares, even under a 10b5-1 plan, could be perceived as a slight negative signal. However, the simultaneous grant of restricted stock units and the pre-planned nature of the sales temper the negative sentiment, suggesting a routine portfolio adjustment rather than a loss of confidence.
Positives
- Acquisition of 2,500 restricted stock units on January 23, 2026, demonstrates continued equity incentive and alignment with shareholder interests.
- The restricted stock units vest 100% on January 23, 2027, indicating a future commitment to the company.
Negatives
- Director Robert C. Patent sold a total of 14,445 shares of common stock over two days, which represents a significant reduction in direct holdings (excluding the RSU grant).
- The sales occurred at various prices, with some transactions at lower prices ($90.044) compared to others ($96.1553).
Risks
- Insider selling, even if pre-planned, can sometimes be perceived negatively by the market, potentially signaling a lack of confidence or a desire to diversify holdings.
- The vesting of restricted stock units on January 27, 2026, and January 23, 2027, could lead to further sales upon vesting, increasing potential selling pressure.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: The net selling by a director, even if pre-planned, might be viewed with caution, potentially leading to minor downward pressure or a perception of reduced insider confidence. The RSU grant, however, aligns the director's future interests with shareholders.
Next Steps
- The 2,500 restricted stock units are scheduled to vest on January 23, 2027.
- Other restricted stock units included in direct ownership are scheduled to vest on January 27, 2026.
Key Dates
| Date | Description |
|---|---|
| 01/22/2026 | Director Robert C. Patent sold 4,998 shares of common stock at a weighted average price of $94.6373. |
| 01/22/2026 | Director Robert C. Patent sold 4,588 shares of common stock at a weighted average price of $95.2753. |
| 01/22/2026 | Director Robert C. Patent sold 414 shares of common stock at a weighted average price of $96.1553. |
| 01/23/2026 | Director Robert C. Patent sold 912 shares of common stock at a weighted average price of $90.044. |
| 01/23/2026 | Director Robert C. Patent sold 1,433 shares of common stock at a weighted average price of $92.1361. |
| 01/23/2026 | Director Robert C. Patent sold 2,100 shares of common stock at a weighted average price of $93.3577. |
| 01/23/2026 | Director Robert C. Patent acquired 2,500 restricted stock units (RSUs) at $0. |
| 01/26/2026 | Date of filing of the Form 4. |
| 01/27/2026 | Vesting date for certain restricted stock units included in direct beneficial ownership. |
| 01/23/2027 | Vesting date for the 2,500 restricted stock units acquired on January 23, 2026. |
Recommendation
holdWhile the director sold a significant number of shares, the transactions were executed under a Rule 10b5-1 plan, suggesting they were pre-scheduled and not necessarily indicative of new negative information. The simultaneous grant of restricted stock units also shows continued alignment with the company's future performance. Given the mixed signals (selling vs. RSU grant and 10b5-1 plan), a 'hold' recommendation is appropriate, advising investors to monitor future insider activity and company performance rather than making immediate buy or sell decisions based solely on this filing.
Keywords
Metropolitan Bank Holding Corp., MCB, insider trading, Form 4, director stock sale, restricted stock units, RSU, beneficial ownership, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.